BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tortosa C, Cabrera-Marante O, Serrano M, Martínez-Flores JA, Pérez D, Lora D, Morillas L, Paz-Artal E, Morales JM, Pleguezuelo D, Serrano A. Incidence of thromboembolic events in asymptomatic carriers of IgA anti ß2 glycoprotein-I antibodies. PLoS One 2017;12:e0178889. [PMID: 28727732 DOI: 10.1371/journal.pone.0178889] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Estévez MÁ, Lanio N, Molina Á, Jiménez-León MR, Picado MJ, Esteban E, Sánchez S, Pallarés L, Julià MR. Extra-criteria antiphospholipid antibodies in patients with small vessel brain lesions and clinical manifestations associated with antiphospholipid syndrome. J Stroke Cerebrovasc Dis 2023;32:107034. [PMID: 36842350 DOI: 10.1016/j.jstrokecerebrovasdis.2023.107034] [Reference Citation Analysis]
2 Naranjo L, Stojanovich L, Djokovic A, Andreoli L, Tincani A, Maślińska M, Sciascia S, Infantino M, Garcinuño S, Kostyra-grabczak K, Manfredi M, Regola F, Stanisavljevic N, Milanovic M, Saponjski J, Roccatello D, Cecchi I, Radin M, Benucci M, Pleguezuelo D, Serrano M, Shoenfeld Y, Serrano A. Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome. Front Immunol 2022;13:957201. [DOI: 10.3389/fimmu.2022.957201] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Huang Y, Liu H, Qi W, Du L, Li M, Zeng X, Guo X, Zhao J, Zhang S. Sex Differences in Clinical Characteristics and Prognosis in Primary Thrombotic Antiphospholipid Syndrome. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.895098] [Reference Citation Analysis]
4 Yacoub MS, Khine J, Najar A, Yadlapalli S. Evidence of Thrombogenesis Recurrence Induced by IgA Antiphospholipid Antibody β2 Glycoprotein I-Dependent in Early Adulthood. Cureus 2022. [DOI: 10.7759/cureus.23535] [Reference Citation Analysis]
5 Su Z, Huang Z, Zhao J, Li M, Hu J, Zeng X, Hu C, Yang B. Detection of IgA Antiphospholipid Antibodies Does not Improve Thrombotic Antiphospholipid Syndrome Classification: A two-Center Study. Clin Appl Thromb Hemost 2022;28:10760296221081129. [PMID: 35379020 DOI: 10.1177/10760296221081129] [Reference Citation Analysis]
6 Meroni PL, Borghi MO. Antiphospholipid Antibody Assays in 2021: Looking for a Predictive Value in Addition to a Diagnostic One. Front Immunol 2021;12:726820. [PMID: 34621272 DOI: 10.3389/fimmu.2021.726820] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
7 Demir S, Li J, Magder LS, Petri M. Antiphospholipid patterns predict risk of thrombosis in systemic lupus erythematosus. Rheumatology (Oxford) 2021;60:3770-7. [PMID: 33331921 DOI: 10.1093/rheumatology/keaa857] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
8 Szabó G, Antal-Szalmás P, Kerényi A, Pénzes K, Bécsi B, Kappelmayer J. Laboratory Approaches to Test the Function of Antiphospholipid Antibodies. Semin Thromb Hemost 2021. [PMID: 34261151 DOI: 10.1055/s-0041-1730357] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
9 Capozzi A, Riitano G, Mancuso S, Recalchi S, Manganelli V, Garofalo T, Alessandri C, Longo A, Misasi R, Conti F, Truglia S, Sorice M. Anti-vimentin/cardiolipin IgA in the anti-phospholipid syndrome: A new tool for 'seronegative' diagnosis. Clin Exp Immunol 2021;205:326-32. [PMID: 34107056 DOI: 10.1111/cei.13633] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Naranjo L, Ostos F, Gil-Etayo FJ, Hernández-Gallego J, Cabrera-Marante Ó, Pleguezuelo DE, Díaz-Simón R, Cerro M, Lora D, Martínez-Salio A, Serrano A. Presence of Extra-Criteria Antiphospholipid Antibodies Is an Independent Risk Factor for Ischemic Stroke. Front Cardiovasc Med 2021;8:665741. [PMID: 34012984 DOI: 10.3389/fcvm.2021.665741] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
11 Huang S, Ninivaggi M, Chayoua W, de Laat B. VWF, Platelets and the Antiphospholipid Syndrome. Int J Mol Sci 2021;22:4200. [PMID: 33919627 DOI: 10.3390/ijms22084200] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
12 Nurbaeva KS, Cheldieva FA, Shumilova AA, Lila AM, Reshetnyak TM. Thromboembolic complications in antiphospholipid syndrome and ankylosing spondylitis (two clinical cases). Sovremennaâ revmatologiâ 2021;15:98-104. [DOI: 10.14412/1996-7012-2021-1-98-104] [Reference Citation Analysis]
13 Chighizola CB, Borghi MO, Meroni PL. Antibodies and diagnostic tests in antiphosholipid syndrome. Systemic Lupus Erythematosus 2021. [DOI: 10.1016/b978-0-12-814551-7.00059-3] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Cabrera-Marante O, Rodríguez de Frías E, Serrano M, Lozano Morillo F, Naranjo L, Gil-Etayo FJ, Paz-Artal E, Pleguezuelo DE, Serrano A. The Weight of IgA Anti-β2glycoprotein I in the Antiphospholipid Syndrome Pathogenesis: Closing the Gap of Seronegative Antiphospholipid Syndrome. Int J Mol Sci 2020;21:E8972. [PMID: 33255963 DOI: 10.3390/ijms21238972] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
15 Hu C, Li X, Zhao J, Wang Q, Li M, Tian X, Zeng X. Immunoglobulin A Isotype of Antiphospholipid Antibodies Does Not Provide Added Value for the Diagnosis of Antiphospholipid Syndrome in a Chinese Population. Front Immunol 2020;11:568503. [PMID: 33123140 DOI: 10.3389/fimmu.2020.568503] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
16 Chayoua W, Yin DM, Kelchtermans H, Moore GW, Gris JC, Musiał J, Zuily S, Ten Cate H, de Laat B, Devreese KMJ. Is There an Additional Value in Detecting Anticardiolipin and Anti-β2 glycoprotein I IgA Antibodies in the Antiphospholipid Syndrome? Thromb Haemost 2020;120:1557-68. [PMID: 32696448 DOI: 10.1055/s-0040-1714653] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
17 Salle V. [Seronegative antiphospholipid syndrome: Myth or reality?]. Rev Med Interne 2020;41:265-74. [PMID: 32115196 DOI: 10.1016/j.revmed.2020.02.005] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
18 Elbagir S, Mohammed NA, Kaihola H, Svenungsson E, Gunnarsson I, Manivel VA, Pertsinidou E, Elagib EM, Nur MAM, Elussein EA, Elshafie A, Åkerud H, Rönnelid J. Elevated IgA antiphospholipid antibodies in healthy pregnant women in Sudan but not Sweden, without corresponding increase in IgA anti-β2 glycoprotein I domain 1 antibodies. Lupus 2020;29:463-73. [PMID: 32106789 DOI: 10.1177/0961203320908949] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
19 Pignatelli P, Ettorre E, Menichelli D, Pani A, Violi F, Pastori D. Seronegative antiphospholipid syndrome: refining the value of "non-criteria" antibodies for diagnosis and clinical management. Haematologica 2020;105:562-72. [PMID: 32001534 DOI: 10.3324/haematol.2019.221945] [Cited by in Crossref: 54] [Cited by in F6Publishing: 55] [Article Influence: 18.0] [Reference Citation Analysis]
20 Serrano M, Morán L, Martinez-Flores JA, Mancebo E, Pleguezuelo D, Cabrera-Marante O, Delgado J, Serrano A. Immune Complexes of Beta-2-Glycoprotein I and IgA Antiphospholipid Antibodies Identify Patients With Elevated Risk of Thrombosis and Early Mortality After Heart Transplantation. Front Immunol 2019;10:2891. [PMID: 31921152 DOI: 10.3389/fimmu.2019.02891] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
21 Bettacchioli E, Nafai S, Renaudineau Y. News and meta-analysis regarding anti-Beta 2 glycoprotein I antibodies and their determination. Clinical Immunology 2019;205:106-15. [DOI: 10.1016/j.clim.2019.06.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
22 Serrano M, Martinez-Flores JA, Norman GL, Naranjo L, Morales JM, Serrano A. The IgA Isotype of Anti-β2 Glycoprotein I Antibodies Recognizes Epitopes in Domains 3, 4, and 5 That Are Located in a Lateral Zone of the Molecule (L-Shaped). Front Immunol 2019;10:1031. [PMID: 31134087 DOI: 10.3389/fimmu.2019.01031] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
23 Morales JM, Serrano M, Martinez-flores JA, Perez D, Serrano A. Antiphospholipid Syndrome and Renal Allograft Thrombosis. Transplantation 2019;103:481-6. [DOI: 10.1097/tp.0000000000002510] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
24 Wysokinska E, Ortel TL. Antiphospholipid Syndrome. Consultative Hemostasis and Thrombosis 2019. [DOI: 10.1016/b978-0-323-46202-0.00020-0] [Reference Citation Analysis]
25 Litvinova E, Darnige L, Kirilovsky A, Burnel Y, de Luna G, Dragon-Durey MA. Prevalence and Significance of Non-conventional Antiphospholipid Antibodies in Patients With Clinical APS Criteria. Front Immunol 2018;9:2971. [PMID: 30619328 DOI: 10.3389/fimmu.2018.02971] [Cited by in Crossref: 44] [Cited by in F6Publishing: 46] [Article Influence: 8.8] [Reference Citation Analysis]
26 Pérez D, Stojanovich L, Naranjo L, Stanisavljevic N, Bogdanovic G, Serrano M, Serrano A. Presence of Immune Complexes of IgG/IgM Bound to B2-glycoprotein I Is Associated With Non-criteria Clinical Manifestations in Patients With Antiphospholipid Syndrome. Front Immunol 2018;9:2644. [PMID: 30524428 DOI: 10.3389/fimmu.2018.02644] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
27 Frodlund M, Vikerfors A, Grosso G, Skogh T, Wetterö J, Elvin K, Gunnarsson I, Kastbom A, Dahlström Ö, Rönnelid J, Svenungsson E, Sjöwall C. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual. Clin Exp Immunol 2018;194:27-38. [PMID: 30208508 DOI: 10.1111/cei.13180] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
28 Liu P, Wu M, Zhang N, Chen C, Xiong B, Zhang X. Multimodal computed tomography-guided intravenous rtPA for aborted stroke in a HIV-infected young man: a case report. BMC Infect Dis 2018;18:434. [PMID: 30157782 DOI: 10.1186/s12879-018-3357-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
29 Singh K, Khan G. Antiphospholipid syndrome presenting as acute mesenteric venous thrombosis involving a variant inferior mesenteric vein and successful treatment with rivaroxaban. BMJ Case Reports 2018. [DOI: 10.1136/bcr-2017-223077] [Reference Citation Analysis]
30 Morales JM, Serrano M, Martinez-Flores JA, Gainza FJ, Marcen R, Arias M, Escuin F, Pérez D, Andres A, Martínez MA, Maruri N, Alvarez E, Castañer JL, López-Hoyos M, Serrano A. Pretransplant IgA-Anti-Beta 2 Glycoprotein I Antibodies As a Predictor of Early Graft Thrombosis after Renal Transplantation in the Clinical Practice: A Multicenter and Prospective Study. Front Immunol 2018;9:468. [PMID: 29593726 DOI: 10.3389/fimmu.2018.00468] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
31 Pérez D, Tincani A, Serrano M, Shoenfeld Y, Serrano A. Antiphospholipid syndrome and IgA anti-beta2-glycoprotein I antibodies: when Cinderella becomes a princess. Lupus 2018;27:177-8. [PMID: 29067871 DOI: 10.1177/0961203317738227] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]